NEW BLOOD TEST DEVELOPED TO DIAGNOSE OVARIAN CANCER
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, including Tina’s Wish researchers, Dipanjan Chowdhury, PhD, and Kevin Elias, MD, are… View more
OVARIAN CANCER MAY ACTUALLY ARISE IN FALLOPIAN TUBES
A preliminary study of ovarian cancer finds that in most cases it actually arises in the Fallopian tubes. If confirmed, the study could… View more
MANY PELVIC TUMORS IN WOMEN MAY HAVE COMMON ORIGIN: FALLOPIAN TUBES
OCTOBER 18, 2017 (9:00AM) NYU Langone Health Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes to which… View more
TINA’S WISH GRANTS FOCUS ON EARLY DETECTION OF OVARIAN CANCER
Only 20 percent of women with ovarian cancer are diagnosed at an early stage when more successful treatment options are available, according… View more
TINA’S WISH RAISES $1.6M FOR OVARIAN CANCER RESEARCH AND CELEBRATES ITS 10TH ANNIVERSARY AT THE AMERICAN MUSEUM OF NATURAL HISTORY
NEW YORK, Sept. 29, 2017 /PRNewswire/ — More than 700 Tina’s Wish supporters came together during Ovarian Cancer Awareness Month to raise… View more
LEVINE WEIGHS IN ON PRECISION MEDICINE RAPIDLY BEING INCORPORATED INTO OVARIAN CANCER CARE
Douglas Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center, NYU Langone School of Medicine, sat down with… View more